Key Non-Invasive Glucose Monitoring Devices Market Players:
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Dexcom
- Medtronic
- Roche
- Senseonics
- Ascensia Diabetes Care
- Nemaura Medical
- LifePlus
- Integrity Applications
- Terumo Corporation
- AgaMatrix
- Biolinq
- PKvitality
- GlucoRx
- Cnoga Medical
- Bionime
- i-SENS
- BeatO
- MEDTRUM Technologies
- ForaCare
The presence of dominating players such as Abbott, Dexcom, and Medtronic intensifies the landscape in the global non-invasive glucose monitoring devices market as they leverage the tremendous approved systems to strengthen their ecosystem. Meanwhile, firms such as Roche and Senseonics are making a move through implantable and hybrid solutions. Their strategies to promote AI and ML for predictive analysis are fostering a favorable business environment in this sector.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of non-invasive glucose monitoring devices is assessed at USD 62 million .
Non-Invasive Glucose Monitoring Devices Market size was valued at USD 62 million in 2025 and is projected to reach USD 318 million by the end of 2035, rising at a CAGR of 25.5% during the forecast period, i.e., 2026-2035.
The North America non-invasive glucose monitoring devices market is projected to register the highest share of 38.8%, growing at a CAGR of 9.3% during the forecast period.
The major players in the market are Abbott Laboratories, Dexcom, Medtronic, Roche, Senseonics, Ascensia Diabetes Care, Nemaura Medical, LifePlus, Integrity Applications, Terumo Corporation, AgaMatrix, Biolinq, PKvitality, GlucoRx, Cnoga Medical, Bionime, i-SENS, BeatO, MEDTRUM Technologies, ForaCare, among others.
